Lessons to be learned from periodontitis

Current Opinion in Rheumatology

Volumn 25, Issue 2, 2013, Pages 241-247

  Janssen, Koen M J ^a   Vissink, Arjan ^a   De Smit, Menke J ^a   Westra, Johanna ^a   Brouwer, Elisabeth ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

citrullination; peptidyl arginine deiminase; periodontitis; Porphyromonas gingivalis; rheumatoid arthritis

Indexed keywords

ALPHA ENOLASE; ARGININE; AUTOANTIBODY; CD14 ANTIGEN; CITRULLINE; FIBRIN; FIBRINOGEN; FILAGGRIN; HLA DRB1 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN ARGININE DEIMINASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; VIMENTIN; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; BIOFILM; CELL ACTIVATION; CELL MIGRATION; DAS28; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; EPITHELIUM CELL; ERYTHROCYTE SEDIMENTATION RATE; ETHNICITY; EXTRACELLULAR MATRIX; GENETIC RISK; GENETIC VARIABILITY; GEOGRAPHY; GINGIVITIS; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; MOUTH HYGIENE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; POSITIVE FEEDBACK; PREVENTIVE DENTISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SMOKING; SYNOVIUM; UPREGULATION;

ARTHRITIS, RHEUMATOID; BACTEROIDACEAE INFECTIONS; CITRULLINE; HUMANS; HYDROLASES; IMMUNITY, INNATE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RISK FACTORS;

EID: 84873345578     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835d833d     Document Type: Review

References (60)

1. Mealey BL, Oates TW, American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol 2006; 77:1289-1303.
2. Scannapieco FA, Bush RB, Paju S. Associations between periodontal: a disease and riskfor atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol 2003; 8:38-53.
3. Brito F, de Barros FC, Zaltman C, et al. Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis. J Clin Periodontol 2008; 35:555-560.
4. Routsias JG, Goules JD, Goules A, et al. Autopathogenic correlation of periodontitis and rheumatoid arthritis. Rheumatology (Oxford) 2011; 50:1189-1193.
5. Firestein GS. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J Clin Rheumatol 2005; 11:S39-S44.
6. Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2012; 51 (Suppl 5):v3-v11.
7. Panayi GS. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis? Rheumatology (Oxford) 2005; 44 (Suppl 2):ii3-ii7.
8. Jansson H. Studies on periodontitis and analyses of individuals at risk for periodontal diseases. Swed Dent J Suppl 2006; 180:5-49.
9. Armitage GC. Research, Science and Therapy Committee of the American Academy of Periodontology. Diagnosis of periodontal diseases. J Periodontol 2003; 74:1237-1247.
10. Bonfil JJ, Dillier FL, Mercier P, et al. A 'case control' study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identifica-tion of types and subtypes using molecular biology (PCR. SSO). J Clin Periodontol 1999; 26:77-84.
11. Albandar JM, Streckfus CF, Adesanya MR, Winn DM. Cigar, pipe, and cigarette smoking as risk factors for periodontal disease and tooth loss. J Periodontol 2000; 71:1874-1881.
12. de Heens GL, Kikkert R, Aarden LA, et al. Effects of smoking on the ex vivo cytokine production in periodontitis. J Periodontal Res 2009; 44:28-34.
13. Zhang W, Song F, Windsor LJ. Cigarette smoke condensate affects the collagen-degrading ability of human gingival fibroblasts. J Periodontal Res 2009; 44:704-713.
14. Madianos PN, Bobetsis YA, Kinane DF. Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J Clin Periodontol 2005; 32 (Suppl 6):57-71.
15. Berglundh T, Liljenberg B, Tarkowski A, Lindhe J. The presence of local and circulating autoreactive B cells in patients with advanced periodontitis. J Clin Periodontol 2002; 29:281-286.
16. Tobon GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 2010; 35:10-14.
17. Rantapää-Dahlqvist S. What happens before the onset of rheumatoid arthri-tis? Curr Opin Rheumatol 2009; 21:272-278.
18. Gerlag DM, Raza K, van Baarsen LG, et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis 2012; 71:638-641.
19. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62:2569-2581.
20. Quinn MA, Conaghan PG, Emery P. The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? Rheumatology (Oxford) 2001; 40:1211-1220.
21. Rutger Persson G. Rheumatoid arthritis and periodontitis: inflammatory and infectious connections. Review of the literature. J Oral Microbiol 2012; 4:10. 3402/jom. v4i0. 11829. [Epub 2012 Feb 13]
22. Kallberg H, Ding B, Padyukov L, et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 2011; 70:508-511.
23. Klareskog L, Malmstrom V, Lundberg K, et al. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol 2011; 23:92-98.
24. Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43:155-163.
25. Besada E, Nikolaissen C, Nossent H. Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones's Locker? Scand J Rheumatol 2012; 41:85-88.
26. Wegner N, Lundberg K, Kinloch A, et al. Autoimmunitytospecificcitrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010; 233:34-54.
27. Nielen MM, vanSchaardenburg D, Reesink HW, et al. Specificautoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50:380-386.
28. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, et al. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005; 7:R949-R958.
29. Steiner G, Smolen J. Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 2002; 4 (Suppl 2):S1-S5.
30. Havemose-Poulsen A, Westergaard J, Stoltze K, et al. Periodontal and hematological characteristics associated with aggressive periodontitis, juve-nile idiopathicarthritis, and rheumatoid arthritis. J Periodontol 2006; 77:280-288.
31. Hendler A, Mulli TK, Hughes FJ, et al. Involvement of autoimmunity in the pathogenesis of aggressive periodontitis. J Dent Res 2010; 89:1389-1394.
32. Harvey GP, Fitzsimmons TR, Dhamarpatni AA, et al. Expression of peptidy-larginine deiminase-2and-4, citrullinated proteinsand anticitrullinated protein antibodies in human gingiva. J Periodontal Res 2012. doi: 10. 1111/jre. 12002
33. Foulquier C, Sebbag M, Clavel C, et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 2007; 56:3541-3553.
34. Nesse W, Westra J, van der Wal JE, et al. The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anticitrullinated protein antibody) formation. J Clin Periodontol 2012; 39:599-607.
35. Chapuy-Regaud S, Sebbag M, Baeten D, et al. Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. J Immunol 2005; 174:5057-5064.
36. Makrygiannakis D, Af Klint E, Lundberg IE, et al. Citrullination is an inflamma-tion-dependent process. Ann Rheum Dis 2006; 65:1219-1222.
37. van Winkelhoff AJ, Loos BG, van der Reijden WA, van der Velden U. Porphyromonas gingivalis, Bacteroides forsythus and other putative period-ontal pathogens in subjects with and without periodontal destruction. J Clin Periodontol 2002; 29:1023-1028.
38. McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingi-valis, peptidylarginine deiminase. Infect Immun 1999; 67:3248-3256.
39. Shirai H, Blundell TL, Mizuguchi K. A novel superfamily of enzymes that catalyze the modification of guanidino groups. Trends Biochem Sci 2001; 26:465-468.
40. Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyr-omonas gingivalis citrullinates human fibrinogen and alpha-enolase: implica-tions for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010; 62:2662-2672.
41. Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 2004; 28:311-318.
42. Moen K, Brun JG, Valen M, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006; 24:656-663.
43. Okada M, Kobayashi T, Ito S, et al. Antibody responses to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults. J Periodontol 2011; 82:1433-1441.
44. Hitchon CA, Chandad F, Ferucci ED, et al. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol 2010; 37:1105-1112.
45. Mikuls TR, Thiele GM, Deane KD, et al. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk for future rheumatoid arthritis. Arthritis Rheum 2012; 64:3522-3530.
46. Scher JU, Ubeda C, Equinda M, et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012; 64:3083-3094.
47. De Smit M, Westra J, Vissink A, et al. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res Ther 2012; 14:R222. [Epub ahead of print]
48. Pischon N, Pischon T, Kroger J, et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol 2008; 79:979-986.
49. Dissick A, Redman RS, Jones M, et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol 2010; 81:223-230.
50. Torkzaban P, Hjiabadi T, Basiri Z, Poorolajal J. Effect of rheumatoid arthritis on periodontitis: a historical cohort study. J Periodontal Implant Sci 2012; 42:67-72.
51. Chen HH, Huang N, Chen YM, et al. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann Rheum Dis 2012. [Epub ahead of print] doi: 10. 1136/annrheumdis-2012-201593.
52. Nesse W, Dijkstra PU, Abbas F, et al. Increased prevalence of cardiovascular and autoimmune diseases in periodontitis patients: a cross-sectional study. J Periodontol 2010; 81:1622-1628.
53. Arkema EV, Karlson EW, Costenbader KH. A prospective study of periodontal disease and riskof rheumatoid arthritis. J Rheumatol 2010; 37:1800-1804.
54. Demmer RT, Molitor JA, Jacobs DR Jr, Michalowicz BS. Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study. J Clin Periodontol 2011; 38:998-1006.
55. Susanto H, Nesse W, Kertia N, et al. Prevalence and severity of periodontitis in Indonesian rheumatoid arthritis patients. J Periodontol 2012. [Epub ahead of print]
56. Leszczynska A, Buczko P, Buczko W, Pietruska M. Periodontal pharmacother-apy: an updated review. Adv Med Sci 2011; 56:123-131.
57. Erciyas K, Sezer U, Ustun K, et al. Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Dis 2012. [Epub ahead of print] doi: 10. 1111/odi. 12017.
58. Ribeiro J, Leao A, Novaes AB. Periodontal infection as a possible severity factor for rheumatoid arthritis. J Clin Periodontol 2005; 32:412-416.
59. Al-Katma MK, Bissada NF, Bordeaux JM, et al. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 2007; 13:134-137.
60. Ortiz P, Bissada NF, Palomo L, et al. Periodontal therapy reducesthe severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009; 80:535-540.